sorafenib has been researched along with Embolism in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, X; Luo, Z; Wang, C; Wang, Y; Zeng, J; Zhang, Y | 1 |
1 other study(ies) available for sorafenib and Embolism
| Article | Year |
|---|---|
Sorafenib plus partial splenic embolism for treatment of hepatocellular carcinoma Barcelona stage C combined with hypersplenism: a case series.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; China; Embolism; Humans; Hypersplenism; Liver Neoplasms; Neoplasm Staging; Phenylurea Compounds; Sorafenib; Treatment Outcome | 2021 |